---
title: "Breast cancer survival prediction using HEAL-Surv multimodal distillation"
id: "medrxiv-15-hierarchical-graph-learning-with-multimodal-distillation-for-breast-cancer"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-15-hierarchical-graph-learning-with-multimodal-distillation-for-breast-cancer"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1?rss=1"
published_at: "2026-11-17T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Breast cancer survival prediction using HEAL-Surv multimodal distillation
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-15-hierarchical-graph-learning-with-multimodal-distillation-for-breast-cancer
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1?rss=1)
- **Published At:** 2026-11-17T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Investigators developed HEAL-Surv, a teacher–student framework combining clinical, molecular, **DNA methylation**, and **imaging mass cytometry (IMC)** data for five‑year disease‑specific survival (DSS) prediction. - The teacher model is an additive Cox model that integrates four modalities; a hierarchical IMC graph encoder captures local cell interactions and broader tissue structure. - The student model is trained to predict survival using fewer inputs at inference, learning from observed outcomes and cross‑fitted teacher survival curves. - In five‑fold cross‑validation on 423 METABRIC patients the full teacher achieved a mean five‑year Uno’s concordance of 0.723; removing any modality reduced concordance and raised mean Brier-based errors. - Distillation improved the student: mean five‑year Uno’s concordance rose from 0.658 (student trained on outcomes alone) to 0.704 with distillation; integrated and five‑year Brier scores were higher for the distilled student. - External evaluation: an IMC‑clinical variant trained on METABRIC achieved a five‑year Uno’s concordance of 0.660 on 265 Basel patients without refitting. - All source datasets were previously published cohorts (METABRIC and Basel IMC); no new data were collected and the authors declared no competing interests. - The study team noted that external validation of the student remains necessary; the source did not report prospective clinical deployment or regulatory milestones.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=xN7hfE3T937WpVN8BHAvspKC9lRPeUi9PxIrlEHgHs8-1794954243.459238-1.2.1.1-3yCA4Bo2WaLsrS.rOvD1jJq7JKVnTTxDIYuKjyjk2ZVKm1pdVVolroETGx3Xx3Eq) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Hierarchical Graph Learning with Multimodal Distillation for Breast Cancer Survival Prediction Binh Minh Tran, Van An Nguyen, Quynh Anh Dang, Minh Hai Nguyen Ngoc, Hai Nam Tran, Dang Hung Tran doi: https://doi.org/10.64898/2026.11.14.26368121 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Binh Minh Tran 1 The University of Sydney; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Binh%2BMinh%2BTran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tran%20BM&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABinh%2BMinh%2BTran%2B) Van An Nguyen 2 Hanoi Medical University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Van%2BAn%2BNguyen%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nguyen%20VA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AVan%2BAn%2BNguyen%2B) Quynh Anh Dang 2 Hanoi Medical University; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Quynh%2BAnh%2BDang%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Dang%20QA&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AQuynh%2BAnh%2BDang%2B) Minh Hai Nguyen Ngoc 3 Hanoi Medical University Hospital; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Minh%2BHai%2BNguyen%2BNgoc%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Nguyen%20Ngoc%20MH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AMinh%2BHai%2BNguyen%2BNgoc%2B) Hai Nam Tran 4 University of New South Wales; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Hai%2BNam%2BTran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tran%20HN&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AHai%2BNam%2BTran%2B) Dang Hung Tran 5 Hanoi University of Industry * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dang%2BHung%2BTran%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Tran%20DH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ADang%2BHung%2BTran%2B) * For correspondence: hungtd@haui.edu.vn * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1347403/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1347403/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1347403/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1347403/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1347403/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Imaging mass cytometry (IMC) and DNA methylation can provide complementary information for breast cancer prognosis, yet these measurements may be unavailable for new patients. In this paper, we propose HEAL-Surv, a teacher-student framework that uses both modalities during training to predict five-year net disease-specific survival (DSS) from clinical variables and molecular profiles at inference. An additive Cox teacher integrates all four modalities, using a hierarchical IMC graph encoder to capture local cell relationships and coarser tissue organisation. The student learns from observed outcomes and cross-fitted teacher survival curves, giving more weight to targets that agree across random initialisations. In five-fold cross-validation on 423 METABRIC patients, the full teacher achieved a mean five-year Uno's concordance of 0.723. Removing any modality reduced mean concordance and increased mean Brier-based errors. Relative to the matched student trained on observed outcomes alone, distillation increased mean five-year Uno's concordance from 0.658 to 0.704, with higher integrated and five-year Brier scores. In a separate external evaluation, an IMC-clinical variant trained on METABRIC achieved a five-year Uno's concordance of 0.660 on 265 Basel patients without refitting. These findings support multimodal supervision for improving risk discrimination with fewer inference inputs, while external validation of the student remains necessary. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The study used ONLY openly available human data that were originally located at: (1) Basel imaging mass cytometry cohort, Zenodo, https://doi.org/10.5281/zenodo.3518284 (Jackson et al., Nature 2020); (2) METABRIC imaging mass cytometry data, Zenodo, https://doi.org/10.5281/zenodo.5850952 (Danenberg et al.); (3) METABRIC clinical, molecular and DNA methylation data, as released with the previously published studies cited in the manuscript (Ali et al. 2020; Batra et al. 2021; Curtis et al. 2012; Pereira et al. 2016), linked through the released METABRIC patient identifiers. No new data were collected. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All source data analysed in this study are from previously published cohorts and are openly available. The Basel imaging mass cytometry cohort (Jackson et al., Nature 2020) is available on Zenodo (https://doi.org/10.5281/zenodo.3518284). The METABRIC imaging mass cytometry data are available on Zenodo (https://doi.org/10.5281/zenodo.5850952). The METABRIC clinical, molecular and DNA methylation data are available as described in the data availability statements of the original publications cited in the manuscript (Ali et al. 2020; Batra et al. 2021; Curtis et al. 2012; Pereira et al. 2016), and records were linked through the released METABRIC patient identifiers. No new data were generated. ## Funder Information Declared Hanoi Medical University, https://ror.org/01n2t3x97 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.14.26368122v1 "Practical evaluation of AI models to forecast a respiratory seasonal epidemic in Canada")[Next ](https://www.medrxiv.org/content/10.64898/2026.09.02.26362022v2 "Concordance Between a Temple-Worn Optical Wearable and Transcranial Doppler During Exercise and Postural Transitions in Healthy Adults") Posted November 17, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/17/2026.11.14.26368121.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.14.26368121v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/17/2026.11.14.26368121.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Hierarchical Graph Learning with Multimodal Distillation for Breast Cancer Survival Prediction Binh Minh Tran, Van An Nguyen, Quynh Anh Dang, Minh Hai Nguyen Ngoc, Hai Nam Tran, Dang Hung Tran medRxiv 2026.11.14.26368121; doi: https://doi.org/10.64898/2026.11.14.26368121 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.14.26368121v1%26text%3DHierarchical%2520Graph%2520Learning%2520with%2520Multimodal%2520Distillation%2520for%2520Breast%2520Cancer%2520Survival%2520Prediction "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.14.26368121v1%26t%3DHierarchical%2520Graph%2520Learning%2520with%2520Multimodal%2520Distillation%2520for%2520Breast%2520Cancer%2520Survival%2520Prediction "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.14.26368121v1%26title%3DHierarchical%2520Graph%2520Learning%2520with%2520Multimodal%2520Distillation%2520for%2520Breast%2520Cancer%2520Survival%2520Prediction%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.14.26368121v1%26title%3DHierarchical%2520Graph%2520Learning%2520with%2520Multimodal%2520Distillation%2520for%2520Breast%2520Cancer%2520Survival%2520Prediction "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.14.26368121) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.14.26368121v1&count=horizontal&via=&text=Hierarchical%20Graph%20Learning%20with%20Multimodal%20Distillation%20for%20Breast%20Cancer%20Survival%20Prediction&counturl=www.medrxiv.org/content/10.64898/2026.11.14.26368121v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (642) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (925) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (355) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (5045) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (496) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (431) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (681) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1702) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16325) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1245) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7312) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (758) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1100) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5329) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1479) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1844) * [Hematology](https://www.medrxiv.org/collection/hematology) (600) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1387) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16523) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1206) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (702) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (157) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (755) * [Neurology](https://www.medrxiv.org/collection/neurology) (7646) * [Nursing](https://www.medrxiv.org/collection/nursing) (380) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1138) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1302) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1045) * [Oncology](https://www.medrxiv.org/collection/oncology) (3760) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1101) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (413) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (470) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (506) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (144) * [Pathology](https://www.medrxiv.org/collection/pathology) (724) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1872) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (758) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (789) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6169) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (10035) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2550) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1533) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1277) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (664) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (811) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (601) * [Surgery](https://www.medrxiv.org/collection/surgery) (807) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (320) * [Urology](https://www.medrxiv.org/collection/urology) (309) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Review
## Related Clinical Research

- [Circulating immune signatures during pembrolizumab-based neoadjuvant therapy in early triple-negat](https://medichelpline.com/clinical-feed/medrxiv-21-circulating-immune-dynamics-during-neoadjuvant-chemoimmunotherapy-in-early.md)
- [FDA clears Roche’s giredestrant; semaglutide shows efficacy in children with severe obesity](https://medichelpline.com/clinical-feed/stat-news-4-stat-pharmalittle-we-re-reading-about-a-roche-breast-cancer-pill-obesity-drugs.md)
- [FDA approves Roche’s Wilserdly (giredestrant) for ESR1-mutant HR-positive, HER2-negative breast ca](https://medichelpline.com/clinical-feed/stat-news-0-stat-fda-approves-new-breast-cancer-drug-providing-new-option-for-some-patients.md)
- [EHR Phenotype Choice Alters Outcomes: Three Invasive Breast Cancer Definitions Compared in TriNetX](https://medichelpline.com/clinical-feed/plos-one-6-electronic-health-record-phenotype-choice-and-real-world-outcome-estimates-a.md)
- [High-fat Diets Reprogram Intestinal Stem Cells and May Raise Colon Cancer Risk](https://medichelpline.com/clinical-feed/medical-news-today-0-high-fat-diets-leave-memory-in-gut-stem-cells-that-may-fuel-colon-cancer.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.